Exane Derivatives’s OAKTREE CAPITAL GROUP, LLC OAK Stock Holding History

Exane Derivatives’s Portfolio OAK Stock Details OAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,264	Closed	-$607K	–	713
2019 Q2	$607K	Sell	12,264 -3,232	-21%	-$160K	0.11%	152
2019 Q1	$769K	Sell	15,496 -1,130	-7%	-$49.1K	0.15%	131
2018 Q4	$661K	Sell	16,626 -1,678	-9%	-$68.9K	0.12%	152
2018 Q3	$758K	Buy	18,304 +1,930	+12%	+$79.4K	0.14%	132
2018 Q2	$665K	Buy	+16,374	New	+$663K	0.11%	152

Other funds holding OAK

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

GCM

GoodHaven Capital Management Millburn, New Jersey $287M AUM 9.07% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

CSIC

Clifford Swan Investment Counsel Pasadena, California $2.94B AUM 21.31% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Exane Derivatives's OAK Position: Q3 2019 in Review

Exane Derivatives sold out of OAKTREE CAPITAL GROUP, LLC (OAK) in Q3 2019, closing a stake of 12,264 shares — an estimated $607K sold.

Exane Derivatives first reported a position in OAK in Q2 2018 and held it in 5 quarters. The position peaked at $769K in Q1 2019. 21 funds tracked by Wall St. Rank hold OAK as of Q3 2019.

Exane Derivatives reported no remaining OAKTREE CAPITAL GROUP, LLC position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 12,264 OAKTREE CAPITAL GROUP, LLC shares in Q3 2019, an estimated $607K.
Exane Derivatives first reported a position in OAKTREE CAPITAL GROUP, LLC in Q2 2018 and held it in 5 quarters.
Exane Derivatives's OAKTREE CAPITAL GROUP, LLC position peaked at $769K in Q1 2019.
21 funds tracked by Wall St. Rank held OAKTREE CAPITAL GROUP, LLC as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.